Sunrest Lifescience Limited was originally incorporated as "Sunrest Lifescience Private Limited" as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to "Sunrest Lifescience Limited" on March 21, 2023.
The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.
The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital.
The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023.
The Company has acquired 51.45% stake in the Hetvi Lifesciences Private Limited, making it a subsidiary of the Company on March 29, 2025.
Sunrest Lifescience share price as on 02 Mar 2026 is Rs. 45. Over the past 6 months, the Sunrest Lifescience share price has decreased by 11.42% and in the last one year, it has decreased by 25%. The 52-week low for Sunrest Lifescience share price was Rs. 29.55 and 52-week high was Rs. 61.
Sunrest Lifescience Limited was originally incorporated as "Sunrest Lifescience Private Limited" as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to "Sunrest Lifescience Limited" on March 21, 2023.
The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.
The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital.
The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023.
The Company has acquired 51.45% stake in the Hetvi Lifesciences Private Limited, making it a subsidiary of the Company on March 29, 2025.
Sunrest Lifescience share price as on 02 Mar 2026 is Rs. 45. Over the past 6 months, the Sunrest Lifescience share price has decreased by 11.42% and in the last one year, it has decreased by 25%. The 52-week low for Sunrest Lifescience share price was Rs. 29.55 and 52-week high was Rs. 61.
